ArcticZymes AS Announces Formation of ArcticZymes Inc. to Serve the Research and Molecular Diagnostic Market in North America
News Jan 18, 2012
"The formation of a U.S. based subsidiary is a key milestone for our company and our B2B and OEM customers in North America. Our intention is to enable our end users research by facilitating access to our products and technical support in an effective and productive manner," said Jan Buch Andersen, Managing Director of ArcticZymes AS. Mr. Andersen continued, "With our enzymes originating from cold-living organisms in the Arctic Sea North of Norway our mission is to offer unique solutions for contamination control, eliminating sample loss through heat-inactivation contrary to removing the enzyme by extraction. Through the absence of sample loss and unique contamination degrading properties of ArcticZymes enzymes we are offering better signal to noise ratios and better consistency in the research and diagnostic PCR field."
"We are pleased that an organization with exceptional products and technology selected Percorso Life Sciences as its strategic partner in North America," said Mr. Dino DiCamillo, President of Percorso Life Sciences.
ArcticZymes Inc. is an operating entity as of today, and will provide customer service, technical sales, technical support, and product logistics to ArcticZymes customers in North America from Jan 17, 2012.
15th International Conference on Surgical Pathology and Cancer Diagnosis
Apr 15 - Apr 16, 2019